Table 1.
Totals | % | Women | % | Men | % | |
---|---|---|---|---|---|---|
Population | 242,394 | 122,901 | 119,493 | |||
age (years): | ||||||
50-54 | 81,605 | 33.7 | 41,065 | 33.4 | 40,540 | 33.9 |
55-59 | 59,633 | 24.6 | 30,130 | 24.5 | 29,503 | 24.7 |
60-64 | 61,266 | 25.3 | 31,176 | 25.4 | 30,090 | 25.2 |
65-69 | 39,890 | 16.5 | 20,530 | 16.7 | 19,360 | 16.2 |
Successfully-invited population, out of the total population | 230,510 | 97.2 | 117,573 | 97.6 | 112,937 | 96.8 |
Participants, out of the successfully-invited population | 148,265 | 64.3 | 78,916 | 67.1 | 69,349 | 61.4 |
FOBT results for participants | ||||||
Positive | 9,961 | 6.7 | 3,751 | 4.8 | 6,210 | 9.0 |
Negative | 138,165 | 93.2 | 75,091 | 95.2 | 63,074 | 91.0 |
Error | 130 | 0.1 | 71 | 0.1 | 59 | 0.1 |
Lost | 9 | 0.0 | 3 | 0.0 | 6 | 0.0 |
colonoscopy performed after positive FOBT | ||||||
No | 735 | 7.4 | 300 | 8.0 | 435 | 7.0 |
Yes | 9,226 | 92.6 | 3,451 | 92.0 | 5,775 | 93.0 |
Colonoscopy results | ||||||
Negative | 4,639 | 50.3 | 2211 | 64.1 | 2,428 | 42.0 |
N/A or inconclusive | 64 | 0.7 | 20 | 0.6 | 44 | 0.8 |
Premalignant or malignant lesion | 4,523 | 49.0 | 1220 | 35.4 | 3,303 | 57.2 |
Type of premalignant or malignant lesion: | ||||||
Premalignant | 3,952 | 87.4 | 1,034 | 84.8 | 2,918 | 88.3 |
Cancer | 571 | 12.6 | 186 | 15.2 | 385 | 11.7 |
Cancer results: | ||||||
stage I/II | 383 | 67.1 | 118 | 63.4 | 265 | 68.8 |
stage lII/IV | 181 | 31.7 | 65 | 34.9 | 116 | 30.1 |
stage unknown / N/A | 6 | 1.1 | 2 | 1.1 | 4 | 1.0 |
stage lost | 1 | 0.2 | 1 | 0.5 | 0 | 0.0 |